MedTrace Logo

Effect of Low Energy Extracorporeal Shockwave on Patients With Bell's Palsy

NCT07661134 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-06-22

No results posted yet for this study

Summary

This study aims to investigate the effect of low energy extracorporeal shock wave therapy on patients with Bell's palsy.

Conditions

  • Bell Palsy

Interventions

DEVICE

Low energy extracorporeal shockwave therapy

Participants allocated to the experimental group will receive low-energy extracorporeal shockwave therapy (LE-ESWT) using a shockwave device set at a frequency of 10 Hz, energy intensity of 2.5, and a total dose of 2500 shockwaves per session. The treatment will be delivered to two sites along the facial nerve pathway, including the stylomastoid foramen (500 shockwaves) and a point located 1 cm anterior to the ear (2000 shockwaves). Each session will be administered for approximately 15 minutes throughout the intervention period.

OTHER

Selective physical therapy program

Participants will receive a standardized physical therapy program including neuromuscular reeducation and massage therapy. Facial exercises will be performed in front of a mirror to improve symmetry and facial muscle control, with therapist assistance provided as needed. Massage therapy will be applied to the neck, scalp, and facial regions. Each treatment session will last approximately 30 minutes.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Rasha Mohamed El Rewiny, PhD · Ass. Professor, Cairo University

  • Ebtsam Mohamed Fahmy, PhD · Professor, Cairo University

  • Mohamed Helayel Marzouk Helayel, PhD · Lecturer, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-25
Primary Completion
2026-09-25
Completion
2026-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07661134 on ClinicalTrials.gov